20.07.2011 • News

Cathay Industrial Biotech Files For IPO Of Up To $200 Million

China's Cathay Industrial Biotech, the world's largest producer of biobutanol, on Tuesday filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission to raise up to $200 million in an initial public offering of American Depository Shares.

Shanghai, China-based Cathay Industrial Biotech has applied for the listing of the ADSs on the Nasdaq Global Select Market under the symbol "CBIO," the filing showed.

The company, which generated annual sales of $124.6 million in 2010, has two additional product candidates in its development pipeline: I+G, a food flavor enhancer that complements monosodium glutamate (MSG), and a bioprocess technology to produce biobutanol from cellulosic biomass feedstock. The company expects to start commercial sales of I+G by the end of the first half of 2012.

 

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read